Spinocerebellar Ataxia Type 6 Repeat Analysis
NY Approved
Test Overview
Clinical Utility
- Molecular confirmation of a clinical diagnosis
- Identification of at-risk family members
- Assist with treatment/management decisions
- Recurrence risk assessment
Test Details
Genes
CACNA1A
Conditions
- Spinocerebellar Ataxia type 6 (SCA6)
Lab Method
- PCR Fragment Analysis
Ordering Information
Resources
Test Documents
Billing
Targeted Variant Testing